[Our experiences in the treatment of acute leukemias in children].
43 children suffering of acute leucaemia were treated in University Children's Hospital Belgrade during the period of 1969- april 1975. 39 patients were treated as acute lymphoblastic leucaemia (90,7%), and 4 patients as acute nonlymphoblastic leucaemia (9,3%). Complete remission of 34 patients treated as ALL by protocol PARIS 06 was established in 94,1%. All 5 patients suffering of ALL, treated by protocol PARIS 01 LA 72 had complete remission. 85,7 patients treated by protocol 06 AL 66 survived one year. 53,5% patients survived two years, 14,2% three years, and 3,5% survived four years. These facts are not final, because 35% patients are still alive. From 5 patients treated by protocol 01 AL 72 4 patinets are in complete remission, but this period is too short to per mit any conclusion. Meadle survival time for patients suffering of ANLL is 7,5 months. One patient is in complete remission for already 9 months.
D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002644:Chickenpox / Q000209:etiology; D002648:Child; D005069:Evaluation Studies as Topic; D006505:Hepatitis / Q000209:etiology; D006566:Herpesviridae Infections / Q000209:etiology; D006801:Humans; D007251:Influenza, Human / Q000209:etiology; D007938:Leukemia / Q000188:drug therapy*; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents
Nasa iskustva u lecenju akutnih leukemija u dece